JP2002534531A5 - - Google Patents

Download PDF

Info

Publication number
JP2002534531A5
JP2002534531A5 JP2000593622A JP2000593622A JP2002534531A5 JP 2002534531 A5 JP2002534531 A5 JP 2002534531A5 JP 2000593622 A JP2000593622 A JP 2000593622A JP 2000593622 A JP2000593622 A JP 2000593622A JP 2002534531 A5 JP2002534531 A5 JP 2002534531A5
Authority
JP
Japan
Prior art keywords
desdimethylamino
macrolides
dehydroerythromycin
hoffman
robinson
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000593622A
Other languages
English (en)
Japanese (ja)
Other versions
JP4568433B2 (ja
JP2002534531A (ja
Filing date
Publication date
Priority claimed from IT1999MI000061A external-priority patent/IT1306205B1/it
Application filed filed Critical
Publication of JP2002534531A publication Critical patent/JP2002534531A/ja
Publication of JP2002534531A5 publication Critical patent/JP2002534531A5/ja
Application granted granted Critical
Publication of JP4568433B2 publication Critical patent/JP4568433B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000593622A 1999-01-15 2000-01-12 抗炎症活性を有するマクロライド Expired - Fee Related JP4568433B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT99A000061 1999-01-15
IT1999MI000061A IT1306205B1 (it) 1999-01-15 1999-01-15 Macrolidi ad attivita' antiinfiammatoria.
PCT/EP2000/000163 WO2000042055A2 (en) 1999-01-15 2000-01-12 Macrolides with anti-inflammatory activity

Publications (3)

Publication Number Publication Date
JP2002534531A JP2002534531A (ja) 2002-10-15
JP2002534531A5 true JP2002534531A5 (https=) 2006-12-28
JP4568433B2 JP4568433B2 (ja) 2010-10-27

Family

ID=11381492

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000593622A Expired - Fee Related JP4568433B2 (ja) 1999-01-15 2000-01-12 抗炎症活性を有するマクロライド

Country Status (19)

Country Link
US (1) US6455576B1 (https=)
EP (1) EP1144427B1 (https=)
JP (1) JP4568433B2 (https=)
CN (1) CN1151165C (https=)
AT (1) ATE308552T1 (https=)
AU (1) AU769006B2 (https=)
BR (1) BR0007514A (https=)
CA (1) CA2368400C (https=)
DE (1) DE60023647T2 (https=)
ES (1) ES2251966T3 (https=)
HU (1) HU229228B1 (https=)
IL (2) IL144044A0 (https=)
IT (1) IT1306205B1 (https=)
MX (1) MXPA01007164A (https=)
NO (1) NO318982B1 (https=)
RU (1) RU2243230C2 (https=)
SK (1) SK286772B6 (https=)
WO (1) WO2000042055A2 (https=)
ZA (1) ZA200105748B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20010018A2 (en) 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
AU2003264917A1 (en) 2002-07-08 2004-01-23 Pliva - Istrazivacki Institut D.O.O. Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
RS20050008A (sr) 2002-07-08 2007-06-04 Pliva-Istraživački Institut D.O.O., Nova jedinjenja,kompozicije i metode za lečenje inflamatornih oboljenja i stanja
EP1521763A2 (en) * 2002-07-08 2005-04-13 Pliva - Istrazivacki Institut d.o.o. Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
BRPI0410638A (pt) * 2003-04-17 2006-06-13 Sandoz Ag derivados de azitromicina
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
ITMI20040124A1 (it) * 2004-01-29 2004-04-29 Zambon Spa Macrolidi ad attivita' antiinfiammatoria
WO2006130128A2 (en) * 2004-02-18 2006-12-07 Chiron Corporation Methods of identifying anti-inflammatory macrolides
EP1723159B1 (en) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same
WO2006035301A2 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Erythromycin a derivatives as antibacterial agents
ES2337915T3 (es) 2004-10-27 2010-04-30 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Conjugados con adtividad antiinflamatoria.
US20080249034A1 (en) * 2005-03-21 2008-10-09 Zambon S.P.A. Use of Macrolides for Treating Intestinal Inflammation
US7582611B2 (en) * 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
US20110178287A1 (en) 2010-01-19 2011-07-21 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutic delivery
RU2455309C2 (ru) * 2010-07-20 2012-07-10 Открытое Акционерное Общество "Татхимфармпрепараты" Способ получения аморфной формы рокситромицина
GB201608236D0 (en) 2016-05-11 2016-06-22 Fidelta D O O Seco macrolide compounds
TWI830987B (zh) 2020-03-12 2024-02-01 美商碩騰服務公司 免疫調節脲氮雜內酯
WO2021195126A1 (en) 2020-03-24 2021-09-30 Burnet Michael W Anti-infective and anti-viral compounds and compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928387A (en) * 1974-02-04 1975-12-23 Hoffmann La Roche Antibiotic 1745A/X and methods for the production thereof
IT1189285B (it) * 1982-05-28 1988-02-04 Nuovo Consor Sanitar Nazionale Sali dell'antibiotico eritromicina e del suo estere propionico con acidi ad attivita' terapeutica coadiuvante
EP0254534A3 (en) * 1986-07-24 1991-04-17 William S. Robinson Erythromycin derivatives and compositions and use for inhibiting virus replication and disease
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
IT1276901B1 (it) * 1994-12-13 1997-11-03 Zambon Spa Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
KR19980701895A (ko) * 1995-03-08 1998-06-25 이라우치지마 가즈다카 면역관련병 처치제 및 그의 탐색 방법

Similar Documents

Publication Publication Date Title
JP2002534531A5 (https=)
EP2848624B1 (en) 2',4'-substituted nucleosides as antiviral agents
WO2007022073A3 (en) Novel 2'-c-methyl and 4'-c-methyl nucleoside derivatives
CN101287472B (zh) 抗病毒的4'-取代前核苷酸的氨基磷酸酯类化合物
JP2003501474A5 (https=)
JP2008531704A5 (https=)
CA2412564A1 (en) Purine derivatives
WO2004046159A8 (en) Antiviral nucleoside derivatives
IL184162A (en) Preparations containing irna materials, their pharmaceutical compositions and their use in the manufacture of drugs to lower the level of synthetic respiratory virus (rsv) protein, rsv mrna or @ rsv concentration @
CA2379786A1 (en) Purine derivatives
WO2002062290A3 (en) Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
WO2004005313A3 (en) Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
WO2006046030A3 (en) Tetracyclic indole derivatives as antiviral agents
TW201008571A (en) Bicyclic nucleosides and nucleotides as therapeutic agents
WO2005025583A2 (en) Tlr7 ligands for the treatment of hepatitis c
MXPA03011192A (es) Nucleosidos 4'-substituidos.
JP2006514910A5 (https=)
JP2002510633A5 (https=)
JP2021505129A5 (https=)
Leaman et al. Targeted therapy of respiratory syncytial virus in African green monkeys by intranasally administered 2-5A antisense
JP2000159790A5 (https=)
IE63655B1 (en) Antiviral compounds
CA2286511A1 (en) Novel macrolide derivatives
RU2003118500A (ru) Средство для ингибирования репродукции оболоченных вирусов, способ его получения, фармацевтическая композиция и способ ингибирования вирусных инфекций
JP2002539125A5 (https=)